The specter of generic challenges has long loomed around copyright’s famous drug, Viagra, raising questions about the future of related pharmaceutical stakes. While first times saw significant profits, the intellectual property end has allowed the path for cheaper alternatives, potentially lowering revenue and creating a genuine danger for inves… Read More